Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulrike Protzer

Showing results (161-170 of 308) with videos related to

Pageof 31
Sort By:
Notfall & Rettungsmedizin|October 26, 2020
[Erratum to: <i>Strategy for university emergency room management at the beginning of an epidemic using COVID-19 as an example</i>]Michael Dommasch, Friedemann Gebhardt, Ulrike Protzer, et al.
Microbiology Spectrum|April 3, 2024
Arsenic trioxide impacts hepatitis B virus core nuclear localization and efficiently interferes with HBV infectionSamuel Hofmann, Julius Luther, Verena Plank, et al.
The Journal of Allergy and Clinical Immunology|March 8, 2021
Fetomaternal immune cross talk modifies T-cell priming through sustained changes to DC functionMatthew Lacorcia, Sonakshi Bhattacharjee, Kristina Laubhahn, et al.
Nature Reviews. Gastroenterology & Hepatology|July 28, 2018
The hepatitis B epidemic and the urgent need for cure preparednessJeffrey V Lazarus, Timothy Block, Christian Bréchot, et al.
The Journal of Infectious Diseases|March 30, 2012
A new class of synthetic peptide inhibitors blocks attachment and entry of human pathogenic virusesMarcel Krepstakies, Julie Lucifora, Claus-Henning Nagel, et al.
Notfall & Rettungsmedizin|August 25, 2020
[Strategy for university emergency room management at the beginning of an epidemic using COVID-19 as an example]Michael Dommasch, Friedemann Gebhardt, Ulrike Protzer, et al.
Plos Pathogens|June 9, 2022
Hepatitis B virus X protein counteracts high mobility group box 1 protein-mediated epigenetic silencing of covalently closed circular DNAElena S Kim, Jun Zhou, Hu Zhang, et al.
Infection|May 10, 2021
Self-sampling versus health care professional-guided swab collection for SARS-CoV-2 testingSilvia Würstle, Christoph D Spinner, Florian Voit, et al.
Hepatology (Baltimore, Md.)|September 8, 2011
Toll-like receptor 2-mediated innate immune response in human nonparenchymal liver cells toward adeno-associated viral vectorsMarianna Hösel, Mathias Broxtermann, Hanna Janicki, et al.
Clinical and Molecular Hepatology|May 29, 2024
Genetically-modified, redirected T cells target hepatitis B surface antigen-positive hepatocytes and hepatocellular carcinoma lesions in a clinical settingXueshuai Wan, Karin Wisskirchen, Tao Jin, et al.
Pageof 31

Showing results (161-170 of 308) with videos related to

Sort By:
Pageof 31
Notfall & Rettungsmedizin|October 26, 2020
[Erratum to: <i>Strategy for university emergency room management at the beginning of an epidemic using COVID-19 as an example</i>]Michael Dommasch, Friedemann Gebhardt, Ulrike Protzer, et al.
Microbiology Spectrum|April 3, 2024
Arsenic trioxide impacts hepatitis B virus core nuclear localization and efficiently interferes with HBV infectionSamuel Hofmann, Julius Luther, Verena Plank, et al.
The Journal of Allergy and Clinical Immunology|March 8, 2021
Fetomaternal immune cross talk modifies T-cell priming through sustained changes to DC functionMatthew Lacorcia, Sonakshi Bhattacharjee, Kristina Laubhahn, et al.
Nature Reviews. Gastroenterology & Hepatology|July 28, 2018
The hepatitis B epidemic and the urgent need for cure preparednessJeffrey V Lazarus, Timothy Block, Christian Bréchot, et al.
The Journal of Infectious Diseases|March 30, 2012
A new class of synthetic peptide inhibitors blocks attachment and entry of human pathogenic virusesMarcel Krepstakies, Julie Lucifora, Claus-Henning Nagel, et al.
Notfall & Rettungsmedizin|August 25, 2020
[Strategy for university emergency room management at the beginning of an epidemic using COVID-19 as an example]Michael Dommasch, Friedemann Gebhardt, Ulrike Protzer, et al.
Plos Pathogens|June 9, 2022
Hepatitis B virus X protein counteracts high mobility group box 1 protein-mediated epigenetic silencing of covalently closed circular DNAElena S Kim, Jun Zhou, Hu Zhang, et al.
Infection|May 10, 2021
Self-sampling versus health care professional-guided swab collection for SARS-CoV-2 testingSilvia Würstle, Christoph D Spinner, Florian Voit, et al.
Hepatology (Baltimore, Md.)|September 8, 2011
Toll-like receptor 2-mediated innate immune response in human nonparenchymal liver cells toward adeno-associated viral vectorsMarianna Hösel, Mathias Broxtermann, Hanna Janicki, et al.
Clinical and Molecular Hepatology|May 29, 2024
Genetically-modified, redirected T cells target hepatitis B surface antigen-positive hepatocytes and hepatocellular carcinoma lesions in a clinical settingXueshuai Wan, Karin Wisskirchen, Tao Jin, et al.
Pageof 31